Production (Stage)
VentriPoint Diagnostics Ltd.
VPTDF
$0.0919
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 16.75% | -4.77% | -24.95% | 11.31% | -11.76% |
| Total Depreciation and Amortization | -9.84% | -7.32% | -7.26% | -3.23% | -6.87% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.38% | 366.19% | -10.96% | -66.89% | -55.95% |
| Change in Net Operating Assets | 160.19% | -152.36% | 611.98% | -2.74% | 152.95% |
| Cash from Operations | 29.37% | 29.96% | -14.34% | 2.29% | 5.31% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -10.11% | 8.41% | -388.73% | -98.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,438.89% | 1,900.00% | 3,268.62% | -124.76% | -329.79% |
| Foreign Exchange rate Adjustments | -393.26% | 178.08% | -137.78% | -3,633.33% | 45.90% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.17% | 80.96% | 92.94% | -1.32% | 1.70% |